Historical Stock Price
CDTX historical stock prices picture
Cidara Therapeutics (CDTX) has the following price history information. Looking back at CDTX historical stock prices for the last five trading days, on April 16, 2024, CDTX opened at $0.85, traded as high as $0.87 and as low as $0.69, and closed at $0.73. Trading volume was a total of 1.27M shares. On April 17, 2024, CDTX opened at $0.72, traded as high as $0.80 and as low as $0.71, and closed at $0.72. Trading volume was a total of 429.80K shares. On April 18, 2024, CDTX opened at $0.72, traded as high as $0.75 and as low as $0.71, and closed at $0.72. Trading volume was a total of 274.20K shares. On April 19, 2024, CDTX opened at $0.70, traded as high as $0.74 and as low as $0.68, and closed at $0.68. Trading volume was a total of 364.90K shares. On April 22, 2024, CDTX opened at $0.60, traded as high as $0.65 and as low as $0.50, and closed at $0.51. Trading volume was a total of 3.74M shares.

CDTX Historical Stock Prices By Date:

CDTX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cidara Therapeutics shares, starting with a $10,000 purchase of CDTX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/16/2015
End date: 04/22/2024
Start price/share: $15.20
End price/share: $0.51
Dividends collected/share: $0.00
Total return: -96.62%
Average Annual Total Return: -31.29%
Starting investment: $10,000.00
Ending investment: $338.19
Years: 9.02
Date Open High Low Close Volume
04/16/2024 $0.85 $0.87 $0.69 $0.73 1.27M
04/17/2024 $0.72 $0.80 $0.71 $0.72 429.80K
04/18/2024 $0.72 $0.75 $0.71 $0.72 274.20K
04/19/2024 $0.70 $0.74 $0.68 $0.68 364.90K
04/22/2024 $0.60 $0.65 $0.50 $0.51 3.74M
Cidara Therapeutics is a biotechnology company focused on the discovery, development and commercialization of therapeutics designed for patients facing diseases. Co. is focused on infectious diseases and oncology. Co.'s primary product candidate is rezafungin acetate, an intravenous formulation of an echinocandin antifungal. Rezafungin is being developed as a once-weekly therapy for the first-line treatment and prevention of invasive fungal infections. In addition, Co. is using its Cloudbreak® platform to develop a potential new class of drugs called drug-Fc Conjugates, which target respiratory syncytial virus, human immunodeficiency virus, and the SARS-CoV-2 strains causing COVID-19.
Date Close
04/16/2024$0.73
04/17/2024$0.72
04/18/2024$0.72
04/19/2024$0.68
04/22/2024$0.51
CDTX is categorized under the Healthcare sector; below are some other companies in the same sector:

CDXC Historical Stock Prices
CELC Historical Stock Prices
CELG Historical Stock Prices
CEMI Historical Stock Prices
CEMP Historical Stock Prices
CERC Historical Stock Prices
CERCU Historical Stock Prices
CERE Historical Stock Prices
CERS Historical Stock Prices
CERU Historical Stock Prices

Also explore: CDTX shares outstanding history

Email EnvelopeFree CDTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


CDTX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.